Use of Fluoroquinolones in Patients with Chronic Hepatitis C Virus-Induced Liver Failure

AUTOR(ES)

Kojima, H.

FONTE

American Society for Microbiology

RESUMO

Fluroquinolone antibiotics have been reported to have antiviral properties against RNA viruses, including hepatitis C virus (HCV). In the present study, five patients with advanced liver disease secondary to chronic HCV received 500 mg daily of oral ciprofloxacin for 30 days. Serum HCV-RNA levels and liver enzyme abnormalities remained largely unchanged. Thus, the role of fluoroquinolones as antiviral agents for chronic HCV in patients with advanced liver disease appears to be limited.

Documentos Relacionados

• Plasma hydroxy-metronidazole/ metronidazole ratio in hepatitis C virus-induced liver disease
• Use of zidovudine in human immunodeficiency virus-induced hepatitis.
• Visna Virus-Induced Activation of MAPK Is Required for Virus Replication and Correlates with Virus-Induced Neuropathology
• Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation.
• Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity.